D-serine/DsdCXA control of E. coli uropathogenesis
D-serine/DsdCXA control of E. coli uropathogenesis
批准号:
8242649
负责人:
Rodney A. Welch
金额:
$30.99万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-01 至 2014-01-31
关键词:
AffectBacteriaBladderCarbonCatabolismChemotaxisClinicalCytotoxinD-Serine dehydrataseDevelopmentDipeptidesDrug Delivery SystemsEscherichia coliGene ClusterGene ExpressionGene Expression RegulationGenesGeneticGenetic TranscriptionGrantGrowthHemolysinHomologous GeneIn VitroIslandKidneyLaboratoriesLacZ GenesLinkMediatingModelingMusMutationNitrogenPeptidoglycanPhasePhenotypeProteinsRegulationRegulonRoleSepsisSerineSignal TransductionSiteSourceSystemTestingTimeUp-RegulationUrinary tractUrinary tract infectionUropathogenic E. coliVirulenceWorkantimicrobialcell motilitycommunity-acquired UTIfimbriafitnesshuman diseasein vivomutantnosocomial UTInovelnovel vaccinesprotein expressionrecombinasesecretory proteintype 1 fimbriaeuptake
中文摘要
大肠埃希氏菌是社区获得性尿路感染的最常见原因
尿路感染(UTI)和院内尿路感染和败血症的主要原因。我们关注的是一种基因
大肠杆菌尿毒症株CFT073中的argW岛,该菌含有D-CXA基因
丝氨酸利用和I型菌毛fimBE的ipuAB同系物
重组酶。缺乏D-丝氨酸脱氨酶的CFT073 dsdA突变株是
比野生型CFT073更具竞争力的膀胱或肾脏定植实验
受感染的小鼠。与CFT073相比,分别有44和41个基因表达上调和下调。
在小鼠尿路感染过程中受CFT073 dsdA突变体的调控。上调的基因编码P
以及F1C菌毛、溶血素、OmpF、二肽转运体DPPA和几个与
未知函数。CFT073和其他致尿性大肠杆菌显示(+)趋化性
对D-丝氨酸,而不是L-丝氨酸,如大肠杆菌K-12的情况。IpuA具有类似FIMB的开关
以及在小鼠尿路感染过程中的开关活动。A CFT073 dsdA::Lacz
转录融合经历了可逆的相转换,尽管是由一种不明原因的
受ipuA和iPub突变影响的机制。Ipua和ipub还控制着一个FIMS-
一组编码分泌产物的基因的独立可逆相变
包括溶血素。因此,我们的原始假设得到了强有力的支持
D-丝氨酸是调控CFT073毒力基因的重要信号,
尿路中的生长和dsdCXA连接的重组酶介导的相态
除1型菌毛外,重要的尿毒力和适合性因素的调节。我们会
探讨细胞内D-丝氨酸升高导致肌动蛋白表达上调的机制
尿毒力和适合性基因,并确定除FIMs外的其他基因
重组酶。我们将使用CFT073 dsdA突变体作为DsdA关闭状态的模型
目的:研究P菌毛和溶血素在小鼠膀胱壁定植中的作用。
肾脏。本课题的目的是鉴定和鉴定大肠杆菌的毒力基因。
与严重的人类疾病有关。这项工作将有助于开发新的疫苗和
抗菌剂。为此,我们最近获得的证据表明,D-丝氨酸
脱氨酶可以作为一种新的药物靶点来鉴定新的抗菌剂。
英文摘要
Escherichia coli is the most common cause of community-acquired urinary tract infection
(UTI) and a leading cause of nosocomial UTIs and sepsis. We have focused on a genetic
island at argW in E.coli urosepsis strain CFT073 which contains the dsdCXA genes for D-
serine utilization and ipuAB, homologs of fimBE, the type 1 fimbriae phase-switch
recombinases. A CFT073 dsdA mutant lacking D-serine deaminase is 300-fold more
competitive than wild type CFT073 in colonizing the bladder or kidney of experimentally
infected mice. Compared to CFT073, 44 and 41 genes were respectively up- and down-
regulated in the CFT073 dsdA mutant during murine UTI. Up-regulated genes encoded P
and F1C fimbriae, hemolysin, OmpF, a dipeptide transporter DppA, and several genes with
unknown functions. CFT073 as well as other uropathogenic E. coli show (+) chemotaxis
toward D-serine, but not L-serine as is the case E. coli K-12. ipuA has fimB-like ON-to-OFF
and OFF-to-ON fimS switching activity during murine UTI. A CFT073 dsdA::lacZ
transcriptional fusion undergoes reversible phase-switching albeit by an unidentified
mechanism affected by ipuA and ipuB mutations. ipuA and ipuB also control a fimS-
independent reversible phase switch of a set of genes encoding secreted products that
includes the hemolysin. Therefore, we generated strong support of our original hypotheses
that D-serine represents an important signal for regulation of CFT073 virulence genes and
growth in the urinary tract and that the dsdCXA-linked recombinases mediate phase-state
regulation of important urovirulence and fitness factors besides the type 1 fimbriae. We will
investigate the mechanism whereby elevated intracellular D-serine leads to up-regulation of
urovirulence and fitness genes and characterize loci aside from fimS that are controlled by
the recombinases. We will use the CFT073 dsdA mutant as a model of the DsdA OFF state
to study the roles of P fimbriae and hemolysin in colonization of the murine bladder and
kidney. The objective of our project is to identify and characterize virulence genes for E. coli
involved in serious human diseases. This work will aid development of new vaccines and
antimicrobials. To that end, we have recently acquired evidence that the D-serine
deaminase can serve as a novel drug target for identification of new antimicrobials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
D-serine/DsdCXA control of E. coli uropathogenesis
-
批准号:7577111
-
项目类别:
-
资助金额:$34.9万
-
财政年份:2009
-
负责人:Rodney A. Welch
-
依托单位:
D-serine/DsdCXA control of E. coli uropathogenesis
-
批准号:8448312
-
项目类别:
-
资助金额:$29.91万
-
财政年份:2009
-
负责人:Rodney A. Welch
-
依托单位:
D-serine/DsdCXA control of E. coli uropathogenesis
-
批准号:7885633
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2009
-
负责人:Rodney A. Welch
-
依托单位:
D-serine/DsdCXA control of E. coli uropathogenesis
-
批准号:8063183
-
项目类别:
-
资助金额:$30.99万
-
财政年份:2009
-
负责人:Rodney A. Welch
-
依托单位:
D-serine/DsdCXA Control of E coli Uropathogenesis
-
批准号:7558446
-
项目类别:
-
资助金额:$7.8万
-
财政年份:2008
-
负责人:Rodney A. Welch
-
依托单位:
D-Amino acid and tellurite resistance in NIAID Category A bacterial pathogens
-
批准号:7495611
-
项目类别:
-
资助金额:$21.63万
-
财政年份:2007
-
负责人:Rodney A. Welch
-
依托单位:
D-Amino acid and tellurite resistance in NIAID Category A bacterial pathogens
-
批准号:7286614
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2007
-
负责人:Rodney A. Welch
-
依托单位:
StcE, an E.coli O157:H7 Protease Specific for C1-Inh
-
批准号:6697423
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2003
-
负责人:Rodney A. Welch
-
依托单位:
StcE, an E.coli O157:H7 Protease Specific for C1-Inh
-
批准号:7162077
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2003
-
负责人:Rodney A. Welch
-
依托单位:
StcE, an E.coli O157:H7 Protease Specific for C1-Inh
-
批准号:7009264
-
项目类别:
-
资助金额:$32.84万
-
财政年份:2003
-
负责人:Rodney A. Welch
-
依托单位:
StcE, an E.coli O157:H7 Protease Specific for C1-Inh
-
批准号:6579204
-
项目类别:
-
资助金额:$28.62万
-
财政年份:2003
-
负责人:Rodney A. Welch
-
依托单位:
StcE, an E.coli O157:H7 Protease Specific for C1-Inh
-
批准号:6830289
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2003
-
负责人:Rodney A. Welch
-
依托单位:
StcE, an E.coli O157:H7 Protease Specific for C1-Inh
-
批准号:6896325
-
项目类别:
-
资助金额:$2.78万
-
财政年份:2003
-
负责人:Rodney A. Welch
-
依托单位:
D-serine/DsdCXA Control of E. coli Uropathogenesis
-
批准号:6688973
-
项目类别:
-
资助金额:$33.96万
-
财政年份:2002
-
负责人:Rodney A. Welch
-
依托单位:
D-serine/DsdCXA Control of E. coli Uropathogenesis
-
批准号:6827362
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2002
-
负责人:Rodney A. Welch
-
依托单位:
D-serine/DsdCXA Control of E. coli Uropathogenesis
-
批准号:7169920
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2002
-
负责人:Rodney A. Welch
-
依托单位:
D-serine/DsdCXA Control of E. coli Uropathogenesis
-
批准号:7000292
-
项目类别:
-
资助金额:$33.15万
-
财政年份:2002
-
负责人:Rodney A. Welch
-
依托单位:
D-serine/DsdCXA Control of E. coli Uropathogenesis
-
批准号:6569970
-
项目类别:
-
资助金额:$33.97万
-
财政年份:2002
-
负责人:Rodney A. Welch
-
依托单位:
D-serine/DsdCXA control of E. coli uropathogenesis
-
批准号:7626203
-
项目类别:
-
资助金额:$21.96万
-
财政年份:2002
-
负责人:Rodney A. Welch
-
依托单位:
E COLI PATHOGENICITY ISLANDS
-
批准号:2004436
-
项目类别:
-
资助金额:$16.34万
-
财政年份:1997
-
负责人:Rodney A. Welch
-
依托单位:
国内基金
海外基金
Segmented Filamentous Bacteria激活宿主免疫系统抑制其拮抗菌 Enterobacteriaceae维持菌群平衡及其机制研究
-
批准号:81971557
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2019
-
负责人:毛开睿
-
依托单位:
电缆细菌(Cable bacteria)对水体沉积物有机污染的响应与调控机制
-
批准号:51678163
-
项目类别:面上项目
-
资助金额:64.0万元
-
批准年份:2016
-
负责人:许玫英
-
依托单位: